Rhumbline Advisers Takeda Pharmaceutical CO LTD Transaction History
Rhumbline Advisers
- $109 Billion
- Q4 2024
A detailed history of Rhumbline Advisers transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Rhumbline Advisers holds 74,537 shares of TAK stock, worth $998,050. This represents 0.0% of its overall portfolio holdings.
Number of Shares
74,537
Previous 74,349
0.25%
Holding current value
$998,050
Previous $1.06 Million
6.63%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding TAK
# of Institutions
330Shares Held
73.6MCall Options Held
1.96MPut Options Held
165K-
Capital Research Global Investors Los Angeles, CA13.1MShares$176 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.35MShares$71.7 Million0.01% of portfolio
-
Mondrian Investment Partners LTD London, X05.09MShares$68.2 Million1.21% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA4.64MShares$62.1 Million0.05% of portfolio
-
Goldman Sachs Group Inc New York, NY4.56MShares$61.1 Million0.01% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $41.6B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...